Immunology and Microbiology
Transplant Procedure
100%
Monospecific Antibody
94%
Allele
84%
Allotransplantation
66%
Allograft Vasculopathy
52%
Immunosuppression
43%
Next Generation Sequencing
42%
Ciclosporin
30%
HLA Antibody
29%
B Cell
26%
Transplant Rejection
21%
Hematopoietic Stem Cell
21%
Titer
21%
Hematopoietic Stem Cell Transplantation
21%
Immune Complex
21%
Human Leukocyte Antigen
21%
Complement Component C1q
21%
Epitope
21%
Codon
21%
Exon
21%
HLA DRB1 Antigen
21%
Donor Selection
21%
Plasma Cell
21%
Cytotoxic T-Cell
21%
Classification
21%
T Cell
20%
Alloantibody
19%
Mouse
16%
CD8
15%
Complement Component C4d
15%
Genotype
14%
Splenocyte
13%
Enzyme-Linked Immunosorbent Assay
10%
Cytokine
10%
Memory T Cell
10%
Actin
9%
Antiserum
9%
Alloimmunity
8%
C57BL 6 Mouse
7%
HLA Typing
7%
Stem Cell Transplant
7%
Wild Type
6%
Antibody Mediated Rejection
6%
Cardiac Graft Rejection
5%
Smooth Muscle Cell
5%
Artery
5%
CXCR3
5%
Immunoglobulin M
5%
Cell Population
5%
Cell Lysate
5%
Keyphrases
Donor-specific Antibodies
66%
Calcineurin Inhibitors
45%
Allograft Vasculopathy
42%
Next-generation Sequencing
42%
Immunosuppression
42%
HLA Class II Alleles
42%
Cyclosporine
32%
Cardiac Allograft Vasculopathy
25%
Allogeneic
23%
B Cells
23%
HLA Antibodies
23%
HLA Haplotypes
22%
Allospecific
21%
Genotype Imputation
21%
Human Leukocyte Antigen Antibodies
21%
Tertiary Lymphoid Structures
21%
Titer
21%
Hematopoietic Stem Cell Transplantation
21%
Allograft Survival
21%
Cardiac Allograft
21%
Risk Classification
21%
Novel Allele
21%
HLA-DRB1
21%
Donor Selection
21%
HLA-B27
21%
Racial Groups
21%
Epitope Mismatch
21%
DPB1
21%
Molecular Mismatch
21%
Chronic Lung Allograft Dysfunction
21%
Unrelated Hematopoietic Stem Cell Donors
21%
Angiotensin II (Ang II)
21%
Memory CD8+ T Cells
21%
Alloreactive
21%
Antibody Therapy
21%
Myocardial Fibrosis
21%
Alloantibody
19%
T Cells
15%
Solid Organ Transplant
15%
CD-8
15%
Splenocytes
13%
Mismatch Analysis
13%
Actin
12%
Cell-assisted Lipotransfer
11%
Graft Rejection
10%
Next-generation Sequencing Technology
10%
Hematopoetic Stem Cell Transplant
10%
DPA1
10%
Allele-specific Antibodies
10%
Eplet
10%
Medicine and Dentistry
Angiotensin II Receptor Type 2
42%
Cardiac Allograft Vasculopathy
31%
Transplantation
28%
Plasma Cell
23%
Racial Group
21%
Dupuytren Contracture
21%
Adipose Derived Stem Cell
21%
Peritoneum Adhesion
21%
Breast Cancer
21%
Kidney Graft
21%
Cancer Growth
21%
Metastatic Carcinoma
21%
Epitope
21%
Antibodies
21%
Genotype
21%
Immune Response
21%
Graft Rejection
21%
Xenograft
21%
Allograft
21%
Transforming Growth Factor
18%
Fibroblast
17%
B Lymphocyte
16%
Graft Survival
15%
Immunohistochemistry
11%
Alloimmunity
10%
Biological Marker
10%
Receptor Expression
10%
Laparotomy
10%
Clinical Assessment
10%
Cytokine
10%
Mesothelial Cell
10%
T Lymphocyte
9%
Immunoglobulin M
9%
In Vitro
9%
Real-Time Polymerase Chain Reaction
7%
Peritoneal Fluid
7%
Lymphoid Organ
7%
Combination Therapy
7%
Alpha Smooth Muscle Actin
7%
Neoplasm
6%
Cancer Cell
6%
Macrophage
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Immunoglobulin M Antibody
5%
Heart Transplantation
5%
Enzyme Linked Immunosorbent Assay
5%
Immunofluorescence
5%
Immunoglobulin
5%
B Cell
5%
HLA Antibody
5%
